Children’s Ibuprofen Recall: What Parents Need to Know

Nearly 90,000 bottles of children’s ibuprofen have been recalled due to the potential presence of a foreign substance, prompting concerns for parents nationwide. The recall, initiated by Strides Pharma, Inc., affects a specific lot of the company’s Children’s Ibuprofen Oral Suspension. Here’s a comprehensive overview of the situation, what parents should do, and the potential health implications.

What’s Being Recalled?

Strides Pharma, Inc. Is voluntarily recalling approximately 89,592 bottles of its 100-milligram Children’s Ibuprofen Oral Suspension, packaged in 4-fluid-ounce bottles. The medication was manufactured for Taro Pharmaceuticals USA, Inc. And distributed across the United States.

Affected Lot Numbers and Expiration Date

Consumers should check the lot numbers and expiration date on their bottles of Children’s Ibuprofen Oral Suspension. The recalled lot numbers are 7261973A and 7261974A, with an expiration date of January 31, 2027. The recall number is D-0390-2026.

Why Was the Ibuprofen Recalled?

The recall was triggered by complaints received by Strides Pharma regarding the presence of a “gel-like mass and black particles” within the liquid suspension. While the exact nature of the foreign substance is still under investigation, the company took swift action to prevent potential health risks.

FDA Classification: Class II Recall

The U.S. Food and Drug Administration (FDA) has classified this recall as a Class II recall. This means that while the use or exposure to the affected product may cause temporary or medically reversible adverse health consequences, the probability of serious adverse health consequences is considered remote.

What Should Parents Do?

If you have a bottle of Children’s Ibuprofen Oral Suspension with the affected lot numbers and expiration date, you should immediately stop using it. Currently, the FDA report does not provide specific instructions regarding the return or disposal of the recalled product, but recommends discontinuing use.

Potential Health Risks

Although the FDA classifies this as a Class II recall, it’s crucial to err on the side of caution. Ingesting a foreign substance, even if it appears harmless, could potentially cause discomfort or a mild adverse reaction. Parents should monitor their children for any unusual symptoms if they have recently used the recalled ibuprofen.

Ongoing Investigation

Strides Pharma initiated the voluntary recall on March 2, 2026, and the FDA recognized it as a Class II recall on March 16, 2026. The company is currently investigating the source of the contamination and working to prevent similar issues in the future. USA TODAY reached out to Strides Pharma for more information but has not yet received a response.